Corrigendum to "Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients". [Int J Antimicrob Agents 51 (2018) 594-600]

Published Erratum

. 2019 Sep;54(3):380.

doi: 10.1016/j.ijantimicag.2019.07.022. Epub 2019 Aug 6.

Affiliations

¹ Ghent University Hospital, Intensive Care, Ghent, Belgium. Electronic address: sofie.dhaese@ugent.be.
² Faculty of Medicine and School of Pharmacy, University of Queensland, Brisbane, Australia; Royal Brisbane and Women's Hospital, Brisbane, Australia.
³ Ghent University Hospital, Laboratory Medicine, Ghent, Belgium.
⁴ Ghent University Hospital, Laboratory Medicine, Ghent, Belgium; Ghent University, Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium.
⁵ Ghent University Hospital, Intensive Care, Ghent, Belgium.

Published Erratum

Sofie A M Dhaese et al. Int J Antimicrob Agents. 2019 Sep.

. 2019 Sep;54(3):380.

doi: 10.1016/j.ijantimicag.2019.07.022. Epub 2019 Aug 6.

¹ Ghent University Hospital, Intensive Care, Ghent, Belgium. Electronic address: sofie.dhaese@ugent.be.
² Faculty of Medicine and School of Pharmacy, University of Queensland, Brisbane, Australia; Royal Brisbane and Women's Hospital, Brisbane, Australia.
³ Ghent University Hospital, Laboratory Medicine, Ghent, Belgium.
⁴ Ghent University Hospital, Laboratory Medicine, Ghent, Belgium; Ghent University, Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium.
⁵ Ghent University Hospital, Intensive Care, Ghent, Belgium.

No abstract available

Erratum for

Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
Dhaese SAM, Roberts JA, Carlier M, Verstraete AG, Stove V, De Waele JJ. Dhaese SAM, et al. Int J Antimicrob Agents. 2018 Apr;51(4):594-600. doi: 10.1016/j.ijantimicag.2017.12.015. Epub 2017 Dec 22. Int J Antimicrob Agents. 2018. PMID: 29277531